Rangering i aksjer
#35421
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is... Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
Aksjekurs
$0.01657419
Sist synkronisert: 2026-03-13
Handel InhaleRx Limited (IRX)
Pris IRX pris med markedsverdi på B
Markedsverdi av InhaleRx Limited(IRX)
Markedsverdi: $3.93M
Per August 2026 har InhaleRx Limited en markedsverdi på $3.93M. Dette gjør InhaleRx Limited til det 35421st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for InhaleRx Limited fra 2017 til 2026
IRX sammenlignet med topp 5 mest populære stocks
| Pris på IRX |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+138,652,195.90%
|
|
|
|
|
$4.490T
|
+114,190,418.84%
|
|
|
|
|
$4.162T
|
+105,858,537.42%
|
|
|
|
|
$3.676T
|
+93,496,907.75%
|
|
|
|
|
$2.833T
|
+72,050,045.69%
|
